| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4001968 | American Journal of Ophthalmology | 2015 | 9 Pages |
Abstract
In clinical practice, intravitreal injection of ocriplasmin achieved VMT release in approximately one half of treated eyes, with a 27% closure rate for full-thickness MH. Transient ellipsoid changes were evident in 26% of treated eyes, more common in eyes with successful VMT release.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Priya Sharma, Alexander Juhn, Samuel K. Houston, Mitchell Fineman, Allen Chiang, Allen Ho, Carl Regillo,